New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesityOctober 9, 2026
Tech Abridge, University of Texas System enter enterprise-wide agreement for expanded AI-enabled careBy Healthcare Propulsion StaffOctober 9, 20260 Abridge is expanding its clinical AI platform across the University of Texas System through an enterprise-wide agreement with UT REAL…
